What’s shaping our thinking and what’s new

There’s no better way to crystalize a new idea or strategy than to commit it to writing. This is a discipline we employ every day at CG Life. Here’s some of our latest thinking about the industry and where the opportunities are for innovative leaders.

Supporting Biopharma’s Future in Innovation and Personalization

Supporting Biopharma’s Future in Innovation and Personalization

The biopharma industry’s future is grounded in innovation and personalization. Targeted therapies for smaller patient populations. A future that requires ...
Patient workshop, as part of a panel for pharma companies

Five Tips for Maximizing Your Patient Panels

"Keep the sessions on topic. I get it, patients have an insurmountable amount to deal with, and while it’s important ...
Two arms of a clinical trial, with a synthetic and active arm.

Beyond Placebos: The Promise and Limitations of Synthetic Control Arms

Synthetic control arms offer so many benefits. No one gets a placebo and the study arms are near-perfectly matched, providing ...
Patient experience concept.

Three Pillars for Patient Engagement: Understand, Reflect, and Personalize

Below, we share three core pillars for modern, authentic patient engagement––understanding your audience, reflecting their needs via patient-centric resources, and ...
Celebrating International Day of Women And Girls In Science

Celebrating International Day of Women And Girls In Science

We recognize and are inspired by women in science whose dedication, resilience, and pioneering spirits help break down barriers and ...
Oncolytic Viruses: An Overlooked Ally in the Fight Against Cancer

Oncolytic Viruses: An Overlooked Ally in the Fight Against Cancer

Oncolytic viruses are a compelling cancer treatment strategy that is rapidly gaining attention for its elegant and powerful design. However, ...

Living our best CG Life: latest news

April 2024

Digiday: CG Life doubles in size by buying a digital shop to expand its health and sciences targeting

CG Life's CEO David Ormesher sat down with Digiday to share more on the recent acquisition, expanded capabilities, and more.
April 2024

MM+M: CG Life buys Toolhouse to brand itself as ‘science-first, tech-enabled’ firm

Learn more about CG Life's acquisition of Toolhouse in MM+M's recent article featuring an interview with our CEO, David Ormesher.
April 2024

CG Life acquires Toolhouse, significantly expanding technology-enabled omnichannel capabilities

Acquisition doubles agency size, strengthening expertise in creating impactful digital experiences connecting with clinical and patient audiences
February 2024

Fierce Pharma: CG Life hires agency veteran Chris Weber

News coverage of Chris Weber's appointment to SVP of Strategy at CG Life featured in Fierce Pharma's agency updates.
February 2024

CG Life Welcomes Chris Weber as New SVP of Strategy

Healthcare marketing agency veteran Chris Weber has joined CG Life as Senior Vice President of Strategy, bringing more than three decades of industry experience.
February 2024

Strategies & Tactics Magazine features insights from SVP, Susan Stipa

CG Life's Susan Stipa shares tips on responsible storytelling in science in a guest article.
January 2024

MM+M: CG Life CEO David Ormesher on science-backed rebranding push, genAI’s future

David Ormesher, the medical marketing veteran, shares his vision for growth — backed by science — at CG Life.
January 2024

CG Life Unveils Brand Refresh “Shaped by Science”

CG Life, the integrated agency that blends strategic creative, marketing, digital, and communications with science, unveiled its brand's next evolution: “Shaped by Science.”
December 2023

MM+M: 2024 Predictions from Agency 100 Honorees

CG Life's EVP of Biopharma Life Sciences, Susan Stipa, reflects on a productive 2023 while weighing in on trends & predictions for the year ahead alongside industry peers.